The Commercial Determinants of Health and Evidence Synthesis (CODES): methodological guidance for systematic reviews and other evidence syntheses

• Published in: Systematic reviews Vol. 12; no. 1; pp. 1 - 14
• Main Authors: Petticrew, Mark, Glover, Rebecca E., Volmink, Jimmy, Blanchard, Laurence, Cott, Éadaoin, Knai, Cécile, Maani, Nason, Thomas, James, Tompson, Alice, van Schalkwyk, May C. I., Welch, Vivian
• Format: Journal Article
• Language: English
• Published: London BioMed Central 14.09.2023; BMC
• Subjects: Alcohol; Commercial determinants of health; Commodities; Conflicts of interest; Electronic cigarettes; Fossil fuels; Funding bias; Influence; Low income groups; Marketing; Methodology; Methods; Pharmaceutical industry; Social networks; Systematic reviews; Tobacco industry
• ISSN: 2046-4053; 2046-4053
• DOI: 10.1186/s13643-023-02323-0

Abstract Background The field of the commercial determinants of health (CDOH) refers to the commercial products, pathways and practices that may affect health. The field is growing rapidly, as evidenced by the WHO programme on the economic and commercial determinants of health and a rise in researcher and funder interest. Systematic reviews (SRs) and evidence synthesis more generally will be crucial tools in the evolution of CDOH as a field. Such reviews can draw on existing methodological guidance, though there are areas where existing methods are likely to differ, and there is no overarching guidance on the conduct of CDOH-focussed systematic reviews, or guidance on the specific methodological and conceptual challenges. Methods/results CODES provides guidance on the conduct of systematic reviews focussed on CDOH, from shaping the review question with input from stakeholders, to disseminating the review. Existing guidance was used to identify key stages and to provide a structure for the guidance. The writing group included experience in systematic reviews and other forms of evidence synthesis, and in equity and CDOH research (both primary research and systematic reviews). Conclusions This guidance highlights the special methodological and other considerations for CDOH reviews, including equity considerations, and pointers to areas for future methodological and guideline development. It should contribute to the reliability and utility of CDOH reviews and help stimulate the production of reviews in this growing field.